Emi Noguchi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Diffuse Large B Cell Lymphoma

Radiation Induced

Acute Lymphoblastic Leukemia

Top Venues

British journal of cancer

NPJ breast cancer

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Rui Kitadai, Tatsunori Shimoi, Shu Yazaki, Hitomi Sumiyoshi Okuma, Mai Hoshino, Munehiro Ito, Ayumi Saito, Shosuke Kita, Yuki Kojima, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Yasuhiro Fujiwara, Masayuki Yoshida, Kan Yonemori
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine. Breast cancer (Tokyo, Japan) (2024)
Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai, Naohito Yamamoto, Chi-Feng Chung, Yen-Shen Lu, Dwan-Ying Chang, Joohyuk Sohn, Gun Min Kim, Kyung-Hun Lee, Soo-Chin Lee, Tsutomu Iwasa, Hiroji Iwata, Kenichi Watanabe, Kyung Hae Jung, Yuko Tanabe, Seok Yun Kang, Hiroyuki Yasojima, Kenjiro Aogi, Eriko Tokunaga, Sung Hoon Sim, Yoon Sim Yap, Koji Matsumoto, Ling-Ming Tseng, Yoshiko Umeyama, Kazuki Sudo, Yuki Kojima, Tomomi Hata, Aya Kuchiba, Taro Shibata, Kenichi Nakamura, Yasuhiro Fujiwara, Kenji Tamura, Kan Yonemori
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer. NPJ breast cancer 10 (1) (2024)
Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai, Naohito Yamamoto, Chi-Feng Chung, Yen-Shen Lu, Dwan-Ying Chang, Joohyuk Sohn, Gun Min Kim, Kyung-Hun Lee, Soo-Chin Lee, Tsutomu Iwasa, Hiroji Iwata, Kenichi Watanabe, Kyung Hae Jung, Yuko Tanabe, Seok Yun Kang, Hiroyuki Yasojima, Kenjiro Aogi, Eriko Tokunaga, Sung Hoon Sim, Yoon Sim Yap, Koji Matsumoto, Ling-Ming Tseng, Yoshiko Umeyama, Kazuki Sudo, Yuki Kojima, Tomomi Hata, Aya Kuchiba, Taro Shibata, Kenichi Nakamura, Yasuhiro Fujiwara, Kenji Tamura, Kan Yonemori
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer. NPJ breast cancer 10 (1) (2024)
Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai, Naohito Yamamoto, Chi-Feng Chung, Yen-Shen Lu, Dwan-Ying Chang, Joohyuk Sohn, Gun Min Kim, Kyung-Hun Lee, Soo-Chin Lee, Tsutomu Iwasa, Hiroji Iwata, Kenichi Watanabe, Kyung Hae Jung, Yuko Tanabe, Seok Yun Kang, Hiroyuki Yasojima, Kenjiro Aogi, Eriko Tokunaga, Sung Hoon Sim, Yoon Sim Yap, Koji Matsumoto, Ling-Ming Tseng, Yoshiko Umeyama, Kazuki Sudo, Yuki Kojima, Tomomi Hata, Aya Kuchiba, Taro Shibata, Kenichi Nakamura, Yasuhiro Fujiwara, Kenji Tamura, Kan Yonemori
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer. NPJ breast cancer 10 (1) (2024)
Emi Noguchi, Hiroshi Yaginuma, Yasuhiro Fujiwara
Challenges in Expediting the Development of Oncology Drugs. JCO oncology practice (2023)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer (2022)
Shu Yazaki, Yuki Kojima, Hiroshi Yoshida, Shigemasa Takamizawa, Rui Kitadai, Tadaaki Nishikawa, Tatsunori Shimoi, Kazuki Sudo, Ayumi Saito, Hitomi Sumiyoshi Okuma, Maki Tanioka, Emi Noguchi, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Yasuhiro Fujiwara, Yuichiro Ohe, Kan Yonemori
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer. Journal of gynecologic oncology 33 (6) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Shu Yazaki, Roberto Salgado, Tatsunori Shimoi, Masayuki Yoshida, Sho Shiino, Tomoya Kaneda, Yuki Kojima, Hitomi Sumiyoshi Okuma, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Takeshi Murata, Shin Takayama, Akihiko Suto, Yuichiro Ohe, Kan Yonemori
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British journal of cancer 128 (4) (2022)
Chikashi Watase, Sho Shiino, Tatsunori Shimoi, Emi Noguchi, Tomoya Kaneda, Yusuke Yamamoto, Kan Yonemori, Shin Takayama, Akihiko Suto
Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives. Cancers 13 (5) (2021)
Tatsunori Shimoi, Emi Noguchi, Kazuki Sudo, Yu Jo Chua, Kan Yonemori
Critical Appraisal of Adjuvant Platinum-Based Chemotherapy for Basal Subtype Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (31) (2021)
Seiko Bun, Kan Yonemori, Hiroko Sunadoi, Rena Nishigaki, Emi Noguchi, Takuji Okusaka, Toshirou Nishida, Yasuhiro Fujiwara
Safety and Evidence of Off-Label Use of Approved Drugs at the National Cancer Center Hospital in Japan. JCO oncology practice 17 (3) (2020)
Takuji Seo, Emi Noguchi, Masayuki Yoshida, Taisuke Mori, Maki Tanioka, Kazuki Sudo, Akihiko Shimomura, Kan Yonemori, Yasuhiro Fujiwara, Kenji Tamura
Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation. Case reports in oncological medicine 2020 (2020)
Tatsunori Shimoi, Akinobu Hamada, Marifu Yamagishi, Mitsuharu Hirai, Masayuki Yoshida, Tadaaki Nishikawa, Kazuki Sudo, Akihiko Shimomura, Emi Noguchi, Mayu Yunokawa, Kan Yonemori, Chikako Shimizu, Takayuki Kinoshita, Takahiro Fukuda, Yasuhiro Fujiwara, Kenji Tamura
PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system. Cancer science 109 (8) (2018)